<SEC-DOCUMENT>0001144204-17-061269.txt : 20171129
<SEC-HEADER>0001144204-17-061269.hdr.sgml : 20171129
<ACCEPTANCE-DATETIME>20171129080134
ACCESSION NUMBER:		0001144204-17-061269
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20171129
FILED AS OF DATE:		20171129
DATE AS OF CHANGE:		20171129

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Origin Agritech LTD
		CENTRAL INDEX KEY:			0001321851
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE PRODUCTION - CROPS [0100]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51576
		FILM NUMBER:		171226769

	BUSINESS ADDRESS:	
		STREET 1:		NO. 21 SHENG MING YUAN ROAD
		CITY:			CHANGPING DISTRICT BEIJING
		STATE:			F4
		ZIP:			102206
		BUSINESS PHONE:		858-847-9000

	MAIL ADDRESS:	
		STREET 1:		NO. 21 SHENG MING YUAN ROAD
		CITY:			CHANGPING DISTRICT BEIJING
		STATE:			F4
		ZIP:			102206
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tv480386_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 18pt"><B>UNITED
STATES</B></FONT><BR>
<FONT STYLE="font-size: 18pt"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT><BR>
<FONT STYLE="font-size: 12pt"><B>WASHINGTON, D.C. 20549</B></FONT><BR>
<BR>
<FONT STYLE="font-size: 18pt"><B>FORM 6-K</B></FONT><BR>
<BR>
<FONT STYLE="font-size: 10pt"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>PURSUANT TO RULE 13a-16 OR 15d-16 OF</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></FONT><BR>
<BR>
<FONT STYLE="font-size: 10pt"><B>FOR THE MONTH OF NOVEMBER 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>COMMISSION FILE NUMBER <U>000-51576</U></B></FONT><BR>
<BR>
<FONT STYLE="font-size: 18pt"><B>ORIGIN AGRITECH LIMITED </B></FONT><BR>
<FONT STYLE="font-size: 10pt">(Translation of registrant&rsquo;s name into English)</FONT><BR>
<BR>
<FONT STYLE="font-size: 10pt"><B>No. 21 Sheng Ming Yuan Road, Changping District, Beijing 102206</B></FONT><BR>
<FONT STYLE="font-size: 10pt">(Address of principal executive office)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form 20-F <FONT STYLE="font-family: Wingdings">&#120;</FONT> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F <FONT STYLE="font-family: Wingdings">&#168;</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant
by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule
12g3-2(b) under the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Yes <FONT STYLE="font-family: Wingdings">&#168;</FONT> &nbsp;&nbsp;&nbsp;No
<FONT STYLE="font-family: Wingdings">&#120;</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If &ldquo;Yes&rdquo; is marked, indicate below
the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><U>Other Information &ndash; Commercial
License and Collaboration Agreement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-size: 10pt">Origin Agritech
Limited (&ldquo;Origin&rdquo;) and</FONT> KWS SAAT SE (&ldquo;KWS&rdquo;) entered into a commercial license and collaboration agreement
(&ldquo;Agreement&rdquo;) on November 27, 2017. KWS is a global seed company, active in the business of maize, sugar beet and cereal
seed production and marketing, as well as research and development in plant breeding. The Agreement is the continuation of a collaborative
effort dating back to 2011 when the two companies had an agreement under which Origin granted certain rights to certain of its
transgenic traits in maize to KWS and performed certain services on behalf of KWS relating to those traits and accompanying technologies.
This new Agreement provides for the prolongation and extension of the collaboration between the companies covering the rights of
KWS to use the traits for commercial purposes, including marketing seeds with improved performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Under the Agreement, both companies grant
to each other a non-exclusive, transferable and sub-licensable to its affiliates only,  license to use the Origin transgenic
traits and the KWS germplasm and resulting project material for testing, research and development with the primary aim to introgress
the Origin traits into KWS germplasm and test the generated project material for agronomic performance and efficacy. The parties
will develop a project plan, which will cover a budget and project details, and include testing by Origin in China under project
plan protocols. KWS will provide funding according to the project plan, which  plan budget will not include funding for other
operations of Origin. KWS will have rights to certain information about the testing by Origin. KWS will also have testing rights
outside of China, at its own cost and fulfillment of regulatory requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Origin also grants to KWS an exclusive, non-transferable,
sub-licensable commercial license to use the Origin transgenic traits for all purposes related to the production, distribution
and commercialization of the transgenic material developed under the project plan and the defined KWS varieties in China. The license
terms include milestone payments subject to fulfillment of pre-conditions, including regulatory permitting, and royalty fees on sales
based on quantities of seed sold that have the licensed traits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">It is anticipated that royalty revenue
for germplasm would not commence  until fiscal year 2019, after 2018 growing season testing, and trait revenue would not
commence until 2019 at the earliest, after final biotech cultivation approvals by the Chinese government are obtained.
Notwithstanding these predictions, there can be no assurance given that Origin will generate any significant revenues from
the license arrangements or that they will commence as anticipated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The initial term of the Agreement is seven
years, and it will automatically renew for additional terms of three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><B>ORIGIN AGRITECH LIMITED</B></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left; width: 49%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 6%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; width: 30%">&nbsp;</TD>
    <TD STYLE="width: 15%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ William
    Niebur</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">William Niebur</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated: November 29, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B><U>Item No.</U></B></TD><TD><B><U>Description</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left">99.1</TD><TD>Press Release dated November 29, 2017, regarding KWS License
and Collaboration Agreement</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tv480386_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 35%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%; text-align: center"><IMG SRC="seed_logo.jpg"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD NOWRAP STYLE="text-align: center"><I>Agricultural solutions
for today&rsquo;s growing world </I></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>KWS and Origin Agritech Announce Commercial
Biotech Trait and Corn Germplasm License Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>DES MOINES, Iowa and Einbeck,
Germany, November 29, 2017 / &ndash; </B>Origin Agritech Ltd. (Nasdaq: SEED) (&ldquo;Origin&rdquo; or the
&ldquo;Company&rdquo;), an agricultural biotechnology trait and seed provider, announced today that the company has entered
into a commercial biotechnology trait and corn germplasm license agreement with KWS SAAT SE (KWS), one of the world&rsquo;s
leading plant breeding and seed companies. This agreement facilitates KWS&rsquo; entry into China&rsquo;s corn biotechnology
trait and expanded seed market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Under the agreement, Origin will combine insect
resistance and herbicide tolerance traits co-developed by the Chinese Academy of Agriculture Sciences and Origin Agritech into
KWS corn inbred lines. Biotech-enhanced corn is planned to be deployed upon Chinese commercial and regulatory approval. Future
biotech enhanced versions of these products will also be made available to KWS to serve Chinese farmers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&ldquo;KWS has been a strong strategic partner
in the development of Origin&rsquo;s new insect resistant and herbicide tolerant traits, and this agreement is a key milestone
for our company,&rdquo; said Bill Niebur, CEO, Origin Agritech. &ldquo;This collaboration enables Origin to deliver the value of
the new traits when integrated into the strong genetics of KWS. We believe that the deployment envisaged by this and previous agreements
could provide Origin&rsquo;s technology greater access to the future biotech corn market, which we estimate could become a $1 billion
market opportunity.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">KWS has 160 years of plant breeding history,
a 70-country footprint and a strong reputation in China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&ldquo;We are happy about the opportunity
to combine Origin&rsquo;s traits with KWS genetics to develop highly performing insect resistant and herbicide tolerant seed varieties
which would be of high value for the Chinese farmer,&rdquo; said Gyula Szelle, head of East-SE Asia Corn and Oilcrops at KWS. &ldquo;It
will continue to be our ambition to offer our high-quality corn seed to the Chinese market through our affiliates and licensees
there and with regard to future policies.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Aligned with the goals of the China Ministry
of Agriculture, Origin will continue to support the advancement of agricultural biotechnology. The recent 13th Five Year Plan released
by the Chinese government pushes for accelerated development of biotech crops, emphasizing insect control for maize and herbicide
tolerance for soybeans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&ldquo;We are committed to modernizing China&rsquo;s
agriculture system and improving the country&rsquo;s food security,&rdquo; Niebur said. &ldquo;Our partnership and commercial agreement
with KWS will advance Origin&rsquo;s mission of providing agricultural solutions for today&rsquo;s growing world through being
the preferred partner for and from China in biotechnology.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"># # #</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><I>About Origin Agritech Limited</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>Origin Agritech Limited, founded in 1997
and headquartered in Zhong-Guan-Cun (ZGC) Life Science Park in Beijing, is China&rsquo;s leading agricultural biotechnology company,
specializing in crop seed breeding and genetic improvement. Leading the development of crop seed biotechnologies, Origin Agritech&rsquo;s
phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China&rsquo;s Ministry of Agriculture. Over the
years, Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance
(Bt) traits. Origin operates breeding stations nationwide located in key crop-planting regions. Product lines are vertically integrated
for corn. For further information, please visit the Company&rsquo;s website at: http://www.originseed.com.cn or</I> http://www.originseed.com.cn/en/.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>About KWS SAAT SE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>KWS is one of the world&rsquo;s leading
plant breeding companies. In fiscal 2016/17, 4,950 employees in 70 countries generated net sales of EUR 1,080 million and earnings
before interest and taxes (EBIT) of EUR 132 million. A company with a tradition of family ownership, KWS has operated independently
for more than 160 years. It focuses on plant breeding and the production and sale of seed for corn, sugar beet, cereals, rapeseed
and sunflowers. KWS uses leading-edge plant breeding methods to continuously improve yield and resistance to diseases, pests and
abiotic stress. To that end, the company invested EUR 190 million last fiscal year in research and development, 17 percent of its
net sales. For more information: www.kws.com</I><I>. Follow us on Twitter&reg; at https://twitter.com/KWS_Group</I><I>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>*All figures exclude the companies carried
at equity AGRELIANT GENETICS LLC., AGRELIANT GENETICS INC. and KENFENG &ndash; KWS SEEDS CO., LTD.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><I>Forward-Looking Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>This communication contains &ldquo;forward-looking
statements&rdquo; as defined in the federal securities laws, including Section 27A of the Securities Act of 1933 and Section 21E
of the Securities Exchange Act of 1934. Forward-looking statements address expected future business and financial performance and
financial condition, and contain words like &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo;
&ldquo;seek,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo; &ldquo;target,&rdquo; and similar expressions and variations. Forward-looking
statements address matters that are uncertain. Forward-looking statements are not guarantees of future performance and are based
on assumptions and expectations which may not be realized. They also involve risks and uncertainties, many of which are beyond
the company&rsquo;s control. Some of the important factors that could cause the company&rsquo;s actual results to differ materially from those
discussed in forward-looking statements are: failure to develop and market new products and optimally manage product life cycles;
ability to respond to market acceptance, rules, regulations and policies affecting our products; failure to appropriately manage
process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital
markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; natural disasters
and weather events and patterns; ability to protect and enforce the company&rsquo;s intellectual property rights; and separation of underperforming
or non-strategic assets or businesses. The company undertakes no duty to publicly revise or update any forward-looking statements
as a result of future developments, or new information or otherwise, should circumstances change, except as otherwise required
by securities and other applicable laws.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Xin Zhou</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Phone: +86-10-58907556</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Email: xin.zhou@originseed.com.cn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Mandy Schnell</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">KWS SAAT SE, Head of Communications</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Phone: +49-5561-311-334</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Email: mandy.schnell@kws.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>seed_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 seed_logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !; ',# 2(  A$! Q$!_\0
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MMT5RQ;9IV:;8%SWYJS4:X"@>W%/S7VV%H^QH1I]D<TG=MBT445TB,S6]9MM
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M<.>)W*>.?#UQ:W7]G7\$\MM TWDK\N0HKE?$'Q O%MO#EYILT$(NW#7,!(;
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M"ML/AZ/L>FVEUK,T[(LLP7,0X^8D]AVKU3PP1#H=G:37%G)=QQCS1;$!2>Y
M%80\ ^%V;G2(CQ_??_&M30O"NAZ/=M=:?IT<$^W;O4DG'IR:5"Z:N1A[Q:5O
..(Z3_ #THHHKK/0YC_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
